Showing posts with label extreme drug resistance. Show all posts
Showing posts with label extreme drug resistance. Show all posts
Monday, April 05, 2010
Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas
OBJECTIVE: To evaluate drug resistance after exposure to neoadjuvant chemotherapy and to postoperative chemotherapy in epithelial ovarian, fallopian, and primary peritoneal carcinomas.
Subscribe to:
Posts
(
Atom
)
